These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 10985707

  • 41. Ratio of systolic blood pressure to left ventricular end-diastolic pressure at the time of primary percutaneous coronary intervention predicts in-hospital mortality in patients with ST-elevation myocardial infarction.
    Sola M, Venkatesh K, Caughey M, Rayson R, Dai X, Stouffer GA, Yeung M.
    Catheter Cardiovasc Interv; 2017 Sep 01; 90(3):389-395. PubMed ID: 28303647
    [Abstract] [Full Text] [Related]

  • 42. Intra-aortic balloon counterpulsation and delayed revascularization for myocardial infarction and shock in the absence of primary angioplasty: a treatment strategy with or without thrombolysis?
    Drakos SG, Anastasiou-Nana MI, Terrovitis JV, Tsagalou EP, Kanakakis J, Ntalianis A, Lazaris N, Maroulidis G, Venetsanakos J, Bonios M, Nanas JN.
    Coron Artery Dis; 2008 Nov 01; 19(7):521-6. PubMed ID: 18923249
    [Abstract] [Full Text] [Related]

  • 43. Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial.
    Ohman EM, Nanas J, Stomel RJ, Leesar MA, Nielsen DW, O'Dea D, Rogers FJ, Harber D, Hudson MP, Fraulo E, Shaw LK, Lee KL, TACTICS Trial.
    J Thromb Thrombolysis; 2005 Feb 01; 19(1):33-9. PubMed ID: 15976965
    [Abstract] [Full Text] [Related]

  • 44. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial.
    White HD, Assmann SF, Sanborn TA, Jacobs AK, Webb JG, Sleeper LA, Wong CK, Stewart JT, Aylward PE, Wong SC, Hochman JS.
    Circulation; 2005 Sep 27; 112(13):1992-2001. PubMed ID: 16186436
    [Abstract] [Full Text] [Related]

  • 45. Cardiogenic Shock.
    Vahdatpour C, Collins D, Goldberg S.
    J Am Heart Assoc; 2019 Apr 16; 8(8):e011991. PubMed ID: 30947630
    [No Abstract] [Full Text] [Related]

  • 46. Effect of prolonged intra-aortic balloon pumping in patients with cardiogenic shock following acute myocardial infarction.
    Li JL, Xue H, Wang BS, Zhang HY, Yin LH, Shun WD, Wu Y, Wang LX.
    Med Sci Monit; 2007 Jun 16; 13(6):CR270-74. PubMed ID: 17534233
    [Abstract] [Full Text] [Related]

  • 47. Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial.
    French JK, Feldman HA, Assmann SF, Sanborn T, Palmeri ST, Miller D, Boland J, Buller CE, Steingart R, Sleeper LA, Hochman JS, SHOCK Investigators.
    Am Heart J; 2003 Nov 16; 146(5):804-10. PubMed ID: 14597928
    [Abstract] [Full Text] [Related]

  • 48. [Impact of the intra-aortic balloon pump in the mortality due to cardiogenic shock secondary to acute myocardial infarction].
    Arias EA, González-Chon O, García-López SM, Chacón MA, Noriega-Iriondo F, Vega RE, Chávez-Tapia NC.
    Arch Cardiol Mex; 2005 Nov 16; 75(3):260-6. PubMed ID: 16294814
    [Abstract] [Full Text] [Related]

  • 49. Comparison of the Hemodynamic Response to Intra-Aortic Balloon Counterpulsation in Patients With Cardiogenic Shock Resulting from Acute Myocardial Infarction Versus Acute Decompensated Heart Failure.
    Malick W, Fried JA, Masoumi A, Nair A, Zuver A, Huang A, Haythe J, Farr M, Rabbani L, Karmpaliotis D, Kirtane AJ, Topkara VK, Takeda K, Garan AR.
    Am J Cardiol; 2019 Dec 15; 124(12):1947-1953. PubMed ID: 31648782
    [Abstract] [Full Text] [Related]

  • 50. [Successful therapy of patients in therapy-resistant cardiogenic shock with intracoronary, autologous bone marrow stem cell transplantation].
    Brehm M, Strauer BE.
    Dtsch Med Wochenschr; 2007 Sep 15; 132(38):1944-8. PubMed ID: 17853349
    [Abstract] [Full Text] [Related]

  • 51. Emergent angioplasty prevents left ventricular dilation in patients with acute anterior wall myocardial infarction and cardiogenic shock.
    Iwamori K, Sakata K, Kurihara H, Yoshino H, Ishikawa K.
    Clin Cardiol; 2000 Oct 15; 23(10):743-50. PubMed ID: 11061052
    [Abstract] [Full Text] [Related]

  • 52. Cardiogenic shock: a summary of the randomized SHOCK trial.
    Menon V, Fincke R.
    Congest Heart Fail; 2003 Oct 15; 9(1):35-9. PubMed ID: 12556676
    [Abstract] [Full Text] [Related]

  • 53. Correlates for mortality in patients presented with acute myocardial infarct complicated by cardiogenic shock.
    Minha S, Barbash IM, Dvir D, Ben-Dor I, Loh JP, Pendyala LK, Satler LF, Pichard AD, Torguson R, Waksman R.
    Cardiovasc Revasc Med; 2014 Jan 15; 15(1):13-7. PubMed ID: 24444472
    [Abstract] [Full Text] [Related]

  • 54. Intravenous thyroid hormone supplementation in heart failure with cardiogenic shock.
    Malik FS, Mehra MR, Uber PA, Park MH, Scott RL, Van Meter CH.
    J Card Fail; 1999 Mar 15; 5(1):31-7. PubMed ID: 10194658
    [Abstract] [Full Text] [Related]

  • 55. Impedance cardiography for aortic balloon counterpulsation impact assessment on patients hemodynamics during acute myocardial infarction.
    Brazdzionyte J, Macas A.
    Medicina (Kaunas); 2006 Mar 15; 42(11):904-13. PubMed ID: 17172792
    [Abstract] [Full Text] [Related]

  • 56. Rapid complete reversal of systemic hypoperfusion after intra-aortic balloon pump counterpulsation and survival in cardiogenic shock complicating an acute myocardial infarction.
    Ramanathan K, Farkouh ME, Cosmi JE, French JK, Harkness SM, Džavík V, Sleeper LA, Hochman JS.
    Am Heart J; 2011 Aug 15; 162(2):268-75. PubMed ID: 21835287
    [Abstract] [Full Text] [Related]

  • 57. The ability to achieve complete revascularization is associated with improved in-hospital survival in cardiogenic shock due to myocardial infarction: Manitoba cardiogenic SHOCK Registry investigators.
    Hussain F, Philipp RK, Ducas RA, Elliott J, Džavík V, Jassal DS, Tam JW, Roberts D, Garber PJ, Ducas J.
    Catheter Cardiovasc Interv; 2011 Oct 01; 78(4):540-8. PubMed ID: 21547996
    [Abstract] [Full Text] [Related]

  • 58. Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial.
    Fuernau G, Fengler K, Desch S, Eitel I, Neumann FJ, Olbrich HG, de Waha A, de Waha S, Richardt G, Hennersdorf M, Empen K, Hambrecht R, Jung C, Böhm M, Pöss J, Strasser RH, Schneider S, Ouarrak T, Schuler G, Werdan K, Zeymer U, Thiele H.
    Clin Res Cardiol; 2016 Dec 01; 105(12):1030-1041. PubMed ID: 27378612
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators.
    Hochman JS, Boland J, Sleeper LA, Porway M, Brinker J, Col J, Jacobs A, Slater J, Miller D, Wasserman H.
    Circulation; 1995 Feb 01; 91(3):873-81. PubMed ID: 7828316
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.